On the way to rejuvenation using AI and multidisciplinary knowledge!
An AI-generated small-molecule inhibitor treats fibrosis in vivo and in phase I clinical trials.
A small-molecule TNIK inhibitor targets fibrosis in preclinical and clinical models
Posted in biotech/medical, life extension, robotics/AI